Kidney Toxicity of Drugs for the Heart: An Updated Perspective

Carlo Caiati1, Roberto Arrigoni2, Alessandro Stanca1

  • 1Unit of Cardiovascular Diseases, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Metabolites
|March 26, 2025
PubMed

Insights

Cardiovascular drugs can harm kidneys, causing renal dysfunction. This review covers common drug classes and strategies to prevent kidney damage, highlighting oxidative stress roles.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular drugs are essential for treating heart and vascular conditions.
  • These medications can paradoxically lead to kidney damage, including acute or chronic renal dysfunction.
  • Patient factors and drug specifics influence the risk of nephrotoxicity.

Purpose of the Study:

  • To review the renal effects of commonly prescribed cardiovascular drugs.
  • To discuss mechanisms, clinical implications, and management of drug-induced nephrotoxicity.
  • To explore the role of oxidative stress in cardiovascular drug-induced kidney injury.

Main Methods:

  • Literature review of common cardiovascular drug classes.
  • Analysis of mechanisms of renal toxicity for each drug class.
  • Discussion of clinical management and prevention strategies.

Main Results:

  • Diuretics, ACE inhibitors, ARBs, CCBs, beta-blockers, antiplatelets, anticoagulants, statins, and PPIs can all impact renal function.
  • Mechanisms of toxicity are diverse, involving direct cellular damage, hemodynamic changes, and inflammation.
  • Oxidative stress is implicated as a key factor in pathogenesis.

Conclusions:

  • Understanding drug-specific nephrotoxicity is crucial for safe cardiovascular pharmacotherapy.
  • Proactive management strategies are needed to minimize renal adverse events.
  • Further research into oxidative stress pathways may reveal novel therapeutic targets.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
309
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
476
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
50
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
424